leadf
logo-loader
viewFSD Pharma
(
CSE:HUGENASDAQ:HUGE
)

FSD Pharma CFO bolsters World Class Extractions team

It was announced FSD Pharma CFO Donal Carroll will join the board of directors or management of World Class Extractions Inc

1550185087_shutterstock_283236740.jpg
Carroll has over 15 years of corporate finance leadership and public company experience

FSD Pharma Inc (CSE:HUGE) (OTCQB:FSDDF) chief financial officer Donal Carroll will join the board of directors or management of newly-announced World Class Extractions Inc, according to a statement put out Thursday. 

World Class is an Ontario-incorporated developer of a cannabis extraction process, which intends to provide single-step continuous-flow extraction services to the hemp and cannabis industries. 

READ: FSD Pharma and Canntab Therapeutics forge pact with World Class Extractions to strike hemp deal

Carroll has over 15 years of corporate finance leadership and public company experience, as well as in-depth experience in syndicated investments in equity and debt securities. Throughout his career with Danaher Corporation, Unilever plc, and Cardinal Meat Specialists Ltd, Carroll played roles in major restructuring activities, mergers and acquisitions, and the implementation of new internal controls and enterprise resource planning systems.

Shares of FSD Pharma were at C$0.27 on Thursday. 

Contact Katie Lewis at katie@proactiveinvestors.com

 

Quick facts: FSD Pharma

Follow
CSE:HUGE

Price: 2.07 CAD

Market Cap: $83.95 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

FSD Pharma 'excited' to acquire pharma group Lucid Psycheceuticals to...

FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc (CSE:HUGE) (NASDAQ:HUGE) Interim CEO Anthony Durkacz tells Proactive the group is to buy Canada-based specialty psychedelic pharma group Lucid Psycheceuticals Inc in a stock deal worth around US$9 million (C$11.3 million). Durkacz says the life sciences...

on 08/26/2021

2 min read